Toggle Dropdown
Announcements
Projects
News & Events
Welcome guest
Log in
Loading
Loading...
https://www.prnewswire.com/news-releases/rational-vaccines-announces-a-clinical-trial-to-determine-baseline-characteristics-of-patients-diagnosed-with-recurrent-symptomatic-herpes-simplex-type--2-hsv-2-virus-301605324.html
0
0
Rational Vaccines Announces a Clinical Trial to Determine Baseline Characteristics of Patients Diagnosed With Recurrent Symptomatic Herpes Simplex Type 2 (HSV-2) Virus - PR Newswire
8/15/22 at 12:00pm
Organization
PRNewswire
46 words
0
Comments
/PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced the...
Infectious Diseases
Medical Procedures
Health
Public Health
Rational Vaccines Announces a Clinical Trial
T2DM
HSV-2
PRNewswire
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...